, reiterating its guidance for the fourth quarter, said it expects wafer sales to increase about 130% from the same period a year ago and 50% from the third quarter, but the company's shares were trading at a new 52-week low.
Ibis, based in Danvers, Mass., makes implantation equipment for the semiconductor industry. The company said it is seeing a shift from demand of implanters to demand for separation by implantation of oxygen, or SIMOX, wafers. The company doesn't expect implanter equipment sales in the fourth quarter, but estimated that other equipment revenue will total $800,000 to $900,000.
Analysts polled by
First Call/Thomson Financial
expect the company to lose 9 cents a share for the fourth quarter and 26 cents a share for the year. The company also said it is expanding its SIMOX wafer fab, which should be complete by January.
Shares of Ibis were recently trading through the 52-week low, down $3.13, or 17.5%, to $14.75 in